Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004913 · ClinicalTrials.gov registry record · Phase 1

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

A Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Northwestern University.

Completed
Registry status
Phase 1
Development phase
3
Study locations

NCT00004913 is a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Northwestern University. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004913, a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 1
Development phase
3
Study locations

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid tumors.

Conditions Studied

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

  • DRUG cisplatin
  • DRUG docetaxel
  • DRUG fluorouracil
  • DRUG leucovorin calcium

Study Locations (3)

Illinois

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University - Chicago

Indiana

  • Indiana University Cancer Center - Indianapolis

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia

Trial Details

FieldValue
Start Date 2000-01
Est. Completion 2002-05
Phase Phase 1

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004913

The ClinicalTrials.gov registry entry for NCT00004913 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 4 interventions - of which cisplatin is the first listed.

NCT00004913 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Indiana, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00004913 about?

NCT00004913 is a clinical study titled "Combination Chemotherapy in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have advanced solid ...

What is the current status of trial NCT00004913?

This trial is currently completed. It is a Phase 1 study. The study started on 2000-01. Estimated completion is 2002-05.

What conditions does trial NCT00004913 study?

This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.

What interventions are being tested in trial NCT00004913?

The interventions under investigation include: cisplatin (DRUG), docetaxel (DRUG), fluorouracil (DRUG), leucovorin calcium (DRUG).

Who is sponsoring clinical trial NCT00004913?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004913 being conducted?

This trial has 3 study locations across Illinois, Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Unspecified Adult Solid Tumor, Protocol Specific

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Unspecified Adult Solid Tumor, Protocol Specific

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.